Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
I.Moreno, J. Tomkins, P. Hurtado, E. Okogbenin, A. Dixon & M.Fregene Global Cassava Partnership GCP-I July 22, 2008 Outline I. II. III. IV. V. Introduction Fine Mapping Screening of the TME-3 BAC library Chromosome walking Conclusions Cassava: A Tropical Crop of WorldWide Importance Fifth staple after rice, wheat, maize, and potato World-wide production exceeds 180million tons/year, over half is produced in sub-Saharan Africa (SSA) Demand is expected to increase 2% per year for the next 3 years Constraints: Pests and Diseases Cassava Brown Streak Disease Cassava Mosaic Disease Whiteflies Cassava mealybug Cassava bacterial blight Green spider mite Potential Yield Losses due to Cassava Pests P. herreni P. manihoti Cassava Green Mite Hornworm E. ello Mealybugs 21-53% 34 – 88% 18 – 64% Brown Streak Disease Whiteflies 33 – 79% 30-100% 40-100% Cassava Mosaic Disease The Cassava Mosaic Disease (CMD) A viral disease endemic in SS-Africa and India Not recorded in the Americas Vectored by the white fly (Bemisia tabaci) The Cassava Mosaic Disease (CMD) A viral disease and number one production constraint in SS Africa, yield loss estimated at >US$1billion/year A potential risk in South America and South East Asia, and complicates germplasm transfer from the center of diversity to to SS-Africa Viruses can recombine to more virulent forms and some have associated satellite molecules known to breakdown resistance The most efficient form of control is resistant varieties which take 6-10 years to develop Background IITA (1930) - Sources of resistance I. 3rd Backcrossing : Cassava X Manihot glaziovii (1947) II. Local Nigerian varieties (1990) CIAT (1997) • Fregene 2000 (gen CMD1)Recessive gene • Akano et al 2002 (gen CMD2) Dominant gene • Linkage SSRY28 y NS158 (Akano 2002; Zárate 2002) A single genome region explains >70% of phenotypic variance for CMD resistance and dominance gene action. SSRY NS158 TMS30555 XTME3 Resistant Susceptible R Dist cM Marker Name rGY115 rGY9 7.9 15.6 RP/SP/RB/SB rGY1 200bp CMD2 16.1 rSSRY28 175bp 11.3 Ai19 150bp A single genome region explains 48% of phenotypic variance for CMD resistance and recessive gene action. Resistant Susceptible D Y66 18.5 rI18b 20.5 rJ1a 20.0 rGY57 21.0 rGY25 SSRY 40 TMS30572 X CM7857-4 21.2 SSRY9 23.9 SSRY3 16.2 CMD1 SSRY23 Fine mapping of the CMD2 region 1. Segregant population ( > 1000 individuals) 2. Molecular markers of high resolution. 3. Bulk Segregant Analysis (BSA). 4. Evaluation of molecular markers candidates in recombinant individuals 1. Fine Mapping Population SUSCEPTIBLE PARENTAL RESISTANT PARENTAL TMS 30572 TME-3 X (1690 Individuals) 2. Phenotypical Evaluation Seedling trial- low pressure - Mokwa (IITA) Clonal trial- High pressure of disease (IITA) 3. Bulk Segregant Analysis (BSA) PCR Resistant Bulk Susceptible Recombinant Bulk Resistant Bulk Recombinant Susceptible Bulk R S Monomorphic profile R S Polymorphic profile 1st Level of selection: Parentals and Bulks 2nd Level of Selection: Open Bulks and recombinants individuals Scheme of Fine Mapping F1 POPULATION (TME-3 X TMS 30572) MAPPING OF SSRY28-NS158 MARKERS. PHENOTYPICAL EVALUATION DNA EXTRACTION ( Dellaporta.1993) IDENTIFICATION OF RESISTANCE, SUSCEPTIBLES AND RECOMBINANTS INDIVIDUALS SELECTION OF MOLECULAR MARKERS ASSOCIATED TO CMD2 BULK SEGREGANT ANALYSIS (“BSA”) MAPPING OF MOLECULAR MARKERS DATA ANALYSIS Log-Likelihood : -515.93 Iterations : 3 Longest Seg cM : 27.895 Loop Tolerance : 0.010 Inner Tolerance: 0.010 Linkage map of molecular markers associated to CMD2 Rec Frac. (10.2 %) Dist cM (5) RME-2 (4) (1) RME-1 CMD2 (2) NS158 (3) SSRY28 10.4 ( 4.5 %) 4.5 ( 7.1 %) 7.1 ( 5.9 %) Marker Id Name 5.9 MAPMAKER 2.0 ( θ= 0.3; LOD=5.0) New linkage map ( SSRY28, NS158, RME-1 y RME-2) 27.9 cM Screening of the TME-3 BAC Library 1. Library construction 2. Characterization 3. PCR screening of BAC-Pools 1.Cassava BAC Library Construction HindIII partial digestion Purification and cloning 388b 194kb 48.5kb Mega base pair-sized DNA in Agarose Plugs Size selection Cloning vector BAC LIBRARY (73,728 clones In Micro-titre plates and high density filters) Clone picking by Robotics 97kb 48.5kb 6.9kb Sizing of clones Ligation and Sizing of clones 2. Characterization kb 194.0 145.5 97.0 48.5 pCUGI-1 Coverage 10X N= Ln ( 1-P)/ Ln ( 1- L/G) P= 99% •73,728 clones •4 high density filters •Inserts average = 93 kb (25-250) 3. PCR Screening of the TME-3 library 2 NS158 positive clones 13 RME-1 positivos clones 1 MARKER NS158 PP MARKER RP CP 2 RME-1 LOCATION # 90 N18 189 M19 LOCATION # 12 M14 17 N21 34 L16 47 O3 51 I1 52 A23 54 I1 85 J23 130 D18 136 J8 139 G22 155 K24 173 F1 Chromosome Walking 1. Restriction profile 2. Contig construction 3. BAC-ends Mapping 1. Restriction profile 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 Λ PstI 1 RME-1 NS158 Positive clones were digested with Hind III 2. Contig Construction “Fingerprinting Contig” (“ FPC”) ( Marra et al 1997) 3. BAC-ends Mapping Identification of BAC ends and primer design (RME=6,NS158=4) Cloning and sequencing of amplification products Sequence analysis Design of alleloespecific primers Identification of SSCP markers Results BS BR PS PR 1. SSCP-SNP marker =Bac33b BR BS BRecS 2. SSCP-SNP marker =SBac33c BAC 35 BAC 36 BAC 33 RME--2 RME--1 SBAC 33c BAC 33b Fine mapping BAC 18 BAC 23 BAC 9 Contig Construction SBac33c “Fingerprinting Contig” (“ FPC”) ( Marra et al 1997) Ongoing work Sequencing Minimum tilling path Annotation Candidate genes Genetic Complementation Conclusions • Application of Positional cloning in Cassava for a dominant gene (Fine mapping, Screening of BAC library and Chromosome walking). • Identification of new molecular markers associated to CMD2: RME-1, RME-2, BAC33b and SBAC33c. • Successive screening of the BAC library led to the construction of a contig of BAC clones that stretches for about 500Kb around CMD2. • Five BAC clones that traverse a 500 Kb region around the gene are currently being sequenced to search for candidate R genes that can be tested by genetic complementation. Acknowledgements CIAT Cassava Genetics (Jaime Marin, Edgar Barrera, Paola Alfonso) Myriam Cristina Duque-Statistical support Fernando Rojas- Bioinformatics support CUGI (B. Blackmon, Michael Atkins, Mónica Muñoz, Maria Delgado, Michael Saski) University of Maryland (Pablo Rabinowicz- Comparative Genomics) Cornell University (Sharon Mitchel and Bunmi Olasanmi) University of California-Davis (Ming Cheng Luo and Yanquin Ma). Thank You